Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, explains how the approval of Embrelis marks a pivotal moment ...

In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...

The FDA has decided not to approve glofitamab plus gemcitabine and oxaliplatin to treat certain patients with relapsed/refractory DLBCL.

Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

A Mayo Clinic study confirmed the accuracy of a new FDA-approved blood test for early detection of Alzheimer's disease.

This latest approval builds on an earlier liquid formulation of generic methimazole for feline hyperthyroidism, which ...

The FDA will select at most five companies that align with national priorities, including lower drug prices and increased ...

DSHEA struck a balance between providing easy, affordable access to dietary supplements and maintaining safety and efficacy standards for drugs.

The US Food and Drug Administration has issued 7 warning letters to companies illegally marketing products containing 7-hydroxymitragynine (7-OH), which is found in trace amounts in kratom.

There’s no cure for Alzheimer’s yet, but scientists may be getting closer using an unlikely tool … cancer drugs. Researchers ...